Orforglipron is a new oral GLP-1 drug that outperforms oral semaglutide in blood sugar control and weight loss while offering easier manufacturing and storage, though it may cause more side effects. A once-daily pill now in late-stage testing could push weight loss treatment into a new era. The drug, called orforglipron, is showing stronger results […]This is a curated summary.